NCT03961295View on ClinicalTrials.gov

A Pilot Study to Compare the Pharmacokinetics (PK) of Single Subcutaneous (SC) Injections of Vedolizumab Administered in Prefilled Syringe (PFS) Versus (vs) Prefilled Syringe in Autoinjector (PFS+AI) in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

February 22, 2018

Primary Completion Date

July 14, 2018

Study Completion Date

August 28, 2018

Conditions
Healthy Volunteers
Interventions
DRUG

Vedolizumab SC

Vedolizumab SC liquid.

Trial Locations (1)

68502

Celerion, Lincoln

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY

NCT03961295 - A Pilot Study to Compare the Pharmacokinetics (PK) of Single Subcutaneous (SC) Injections of Vedolizumab Administered in Prefilled Syringe (PFS) Versus (vs) Prefilled Syringe in Autoinjector (PFS+AI) in Healthy Participants | Biotech Hunter | Biotech Hunter